Dan Wilson

Chief Financial Officer, Irhythm Holdings

Search every verified Dan Wilson interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Daniel Wilson, Chief Financial Officer of iRhythm Holdings, appeared on the podcast "Let's Talk MedTech" in April 2026 to discuss the company's Zio monitor, a wearable device that uses FDA-cleared AI for continuous 14-day heart monitoring. He described iRhythm's 20-year history and its focus on addressing undiagnosed arrhythmias, noting that the company serves nearly 3 million patients annually and has over 140 peer-reviewed studies supporting its technology. Wilson discussed the company's expansion into primary care and sleep disorder diagnostics, stating that the sleep market resembles the cardiac monitoring market from 15-20 years ago and that iRhythm could apply a similar approach to home sleep testing. Wilson also addressed the company's strategy for value-based care, saying iRhythm has found success with Medicare Advantage partners who proactively monitor patients for arrhythmias at home rather than waiting for emergency room visits. He emphasized the importance of distilling large amounts of monitoring data into actionable insights for physicians, who face time constraints, and highlighted the role of clinical evidence in building confidence in the company's products. Wilson shared a personal anecdote about a patient who struggled to get a diagnosis before using the Zio monitor, saying such stories keep him grounded in the company's mission.